Longevity Investors & VC Firms in United States
107 firms in this list, with a median first check of $500K. 30 of them lead rounds. Generated from verified public data and updated continuously.
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
Time BioVentures
Southern CaliforniaSeed–Series A
17 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
17 people
Selva Ventures
Los AngelesSeed–Series A$100K – $5M
9 people
Spero Ventures
BurlingameSeed–Series A$2M – $4M
6 people
Kinled Holding
Hong KongSeed–Series A
1 person
PsyMed Ventures
BerkeleyPre-Seed–Series A
12 people
Brookstreet Equity Partners
LondonPre-Seed–Growth
20 people
Iaso Ventures
CambridgeSeed–Series A
12 people
Nordstar
LondonGrowth–Late Stage
9 people
Coyote Ventures
San FranciscoPre-Seed–Series A
14 people
age1
San FranciscoPre-Seed–Series A$500K – $4M
9 people
Magnetic Ventures
BostonSeed–Series A$1M – $6M
9 people
DCVC Bio
Palo AltoSeed–Growth
15 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
Equitage Ventures, L.L.C.
DenverPre-Seed–Late Stage$250K – $2.5M
9 people
Stone Mountain Ventures
DallasPre-Seed–Series A$5M
1 person
Overwater Ventures Llc
Palo AltoPre-Seed–Series A$400K – $2M
7 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
AgeTech Capital
TorontoPre-Seed–Growth
15 people
Todd and Rahul’s Angel Fund
San FranciscoPre-Seed–Series A$300K – $500K
2 people
Fortify Ventures
WashingtonPre-Seed–Seed$100K – $2M
5 people
Pave Health Ventures
SeattlePre-Seed–Series A
12 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.







































)
)
)































